Growing Geriatric Population Fuels Demand For Immunoglobulins Market Driver Leading Immunoglobulins Market Growth: Key Factors Shaping 2025 Expansion

 The Business Research Company’s report on the Immunoglobulins Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

 

 What are the key drivers behind the immunoglobulins market’s growth in recent years?
 The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body’s ability to produce antibodies that protect it from bacteria, viruses, and allergies. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.
 
 Access Your Free Sample of the Global Immunoglobulins Market Report — Get Insights Now!
 https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp
 
 How does the future projection of the immunoglobulins market size compare to its historical growth?
 The immunoglobulins market size has grown strongly in recent years. It will grow from $18.85 billion in 2024 to $20.53 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.
 
 The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $31.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.
 
 Gain Exclusive Market Insights — Customize Your Research Report Today For Fast Delivery!
 https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp
 
 Which key players are shaping the future of the immunoglobulins market?
 Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited
 
 What trends will propel the growth and evolution of the immunoglobulins market?
 Major companies operating in the immunoglobulins market are developing innovative products such as intravenous immunoglobulins to meet larger customer bases, more sales, and increase revenue. For instance, in September 2024, according to the GC Biopharma, a South Korean-based biotechnology company, launched ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, targeting the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older. now available to patients through specialty pharmacies. The launch is significant as the U.S. represents the largest immunoglobulin market globally, valued at approximately $11.6 billion. GC Biopharma aims to achieve $50 million in sales for ALYGLO in its first year, with plans to increase this figure to $300 million by 2028. This ambitious growth strategy involves partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are crucial for distributing immunoglobulin products effectively.
 
 Which regions are expected to become dominant players in the immunoglobulins market?
 North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Order Your Report Now For Swift Delivery
 https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
 
 What are the emerging key segments in the immunoglobulins market, and how are they evolving?
 The immunoglobulins market covered in this report is segmented –
 
 1) By Product: IGG, IGA, IGM, IGE, IGD.
 2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
 3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications
 
 Subsegments:
 1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
 2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
 3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
 4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
 5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD
 
 Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284
 
 How is the immunoglobulins market defined?
 Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication.
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. 
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company